PROVIDER PROFILE · NPI 1043449325

Sherley AramathM.D

PRACTICEARLINGTON FAMILY PRACTICE, P.A.See all providers at this practice →

Family PracticeArlington, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

419

Unique beneficiaries

—

Total services

654

Distinct HCPCS

Medicare payment

$31K

Peer benchmark

Total Medicare services vs. 6,385 Family Practice providers in TX — above median (cohort median 567).

PRESCRIBING · PART D · 2024

Total Rx claims

1,228

Beneficiaries

—

Total drug cost

$167K

Distinct drugs

Brand share

24.2%

Top prescribed drugs

Levothyroxine Sodium104 claims

Atorvastatin Calcium87 claims

Rosuvastatin Calcium79 claims

Metformin Hcl51 claims

Escitalopram Oxalate49 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$469

Payment records

By payment type

Food and Beverage$469

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 450064

Hospital

CCN 450675

Hospital

REFERRAL NETWORK

Where Sherley Aramath's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	31	99

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	59	179
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	19	75

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history